Trial Profile
A Single Treatment, Pharmacokinetic (PK) and Tolerance Study of Natroba (Spinosad) Topical Suspension, 0.9% in Pediatric Subjects 6 Months to 4 Years of Age With an Active Head Lice Infestation.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Apr 2015
Price :
$35
*
At a glance
- Drugs Spinosad (Primary)
- Indications Pediculosis
- Focus Pharmacokinetics
- Sponsors ParaPRO
- 20 Apr 2015 New trial record